Kun Wei Song
Clinical Assistant Professor, Adult Neurology
Clinical Focus
- Neurology
Professional Education
-
Board Certification: United Council for Neurologic Subspecialties, Neuro-Oncology (2023)
-
Medical Education: Duke University School of Medicine (2017) NC
-
Internship: Massachusetts General Hospital Internal Medicine Residency (2018) MA
-
Residency: Brigham and Women's and Mass General Hospital Neurology Residency (2021) MA
-
Fellowship: Massachusetts General Dana Farber Neuro Oncology Fellowship (2022) MA
-
Fellowship: Stanford University Dept of Neurology (2023) CA
-
Board Certification: American Board of Psychiatry and Neurology, Neurology (2021)
-
Board Certification, United Council for Neurologic Subspecialties, Neuro-Oncology, Neuro-Oncology (2023)
Clinical Trials
-
Phase I GD2 CAR T Cells for H3K27M-mutant Diffuse Midline Glioma (DMG)
Recruiting
The primary purpose of this study is to test whether GD2-CAR T cells can be successfully made from immune cells collected from children and young adults with H3K27M-mutant diffuse intrinsic pontine glioma (DIPG) or spinal H3K27M-mutant diffuse midline glioma (DMG). H3K27Mmutant testing will occur as part of standard of care prior to enrollment.
https://orcid.org/0000-0002-4472-230X